Can CYP2C19 help with Schlaf?

CYP2C19 is an enzyme primarily involved in drug metabolism (e.g., certain antidepressants, proton pump inhibitors). There is no direct, robust evidence that CYP2C19 variants meaningfully affect sleep quality or insomnia. Some direct-to-consumer DNA tests suggest a link to sleep medication response, but this is speculative and not supported by clinical guidelines. The effect, if any, is indirect and small. For sleep issues, evidence-based approaches (sleep hygiene, cognitive behavioral therapy, medical evaluation) are far more relevant than genetic testing. Evidence level: marketing/unclear.